Physician profile
Christina M Duffy-Henriques
NPI 1710358437
$18,869.00
in general payments reported to CMS, 2019-2025
68 companies · $3,985 in 2025
The $3,985 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,172 · 2022: $3,133 · 2023: $4,234 · 2024: $4,345 · 2025: $3,985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,961.77 |
| Consulting Fee | $300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Education | $102.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,720.18 | 2021-2025 | |
| Biogen, INC. | $1,667.36 | 2021-2025 | Tysabri, Vumerity, Avonex |
| Neurocrine Biosciences, INC. | $1,444.08 | 2021-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $1,252.00 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $896.29 | 2021-2025 | Nayzilam, Zilbrysq, Rystiggo |
| Genzyme Corporation | $844.91 | 2021-2025 | |
| Emd Serono, INC. | $728.33 | 2021-2025 | Mavenclad |
| Lilly USA, LLC | $712.58 | 2021-2025 | Kisunla, Amyvid, Emgality |
| Alexion Pharmaceuticals, INC. | $633.55 | 2021-2025 | Ultomiris, Soliris |
| Amgen INC. | $598.07 | 2021-2025 | Uplizna |
| Teva Pharmaceuticals USA, INC. | $534.01 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lundbeck LLC | $500.72 | 2021-2025 | Vyepti, Rexulti |
| Eisai INC. | $421.70 | 2021-2025 | |
| Genentech USA, INC. | $386.10 | 2021-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Tg Therapeutics, INC. | $364.37 | 2023-2025 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $332.07 | 2022-2024 | Zeposia |
| Pfizer INC. | $320.50 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $288.95 | 2021 | |
| Horizon Therapeutics Plc | $270.77 | 2021-2023 | Uplizna |
| Otsuka America Pharmaceutical, INC. | $269.67 | 2023-2025 | Rexulti, Nuedexta |
| Jazz Pharmaceuticals INC. | $252.20 | 2021-2024 | Epidiolex |
| Biohaven Pharmaceutical Holding Company Ltd. | $247.27 | 2022 | |
| Csl Behring | $234.95 | 2021-2024 | Hizentra |
| Novartis Pharmaceuticals Corporation | $231.83 | 2021-2024 | |
| Amneal Pharmaceuticals LLC | $231.54 | 2021-2025 | Crexont, Rytary |
| Mdd US Operations, LLC | $215.01 | 2023-2025 | Gocovri, Gocovri |
| Supernus Pharmaceuticals, INC. | $207.36 | 2021-2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $183.35 | 2023-2025 | Hyqvia |
| Neurelis, INC. | $160.21 | 2021-2025 | Valtoco |
| Janssen Pharmaceuticals, INC | $156.54 | 2021-2025 | Spravato |
| Tanabe Pharma America, INC. | $150.16 | 2021-2025 | Radicava |
| Grifols USA, LLC | $140.74 | 2021-2025 | Gamunex-C |
| Celgene Corporation | $138.24 | 2021 | |
| Mallinckrodt Hospital Products INC. | $133.33 | 2021-2023 | Acthar |
| Scilex Pharmaceuticals INC. | $127.93 | 2022-2024 | Ztlido |
| Banner Life Sciences, LLC | $121.59 | 2022-2023 | |
| Upsher-Smith Laboratories LLC | $119.01 | 2021-2023 | |
| Sk Life Science, INC. | $113.01 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $93.82 | 2023-2024 | Aptiom |
| Allergan, INC. | $83.35 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $82.98 | 2024-2025 | Lumryz |
| Livanova USA, INC. | $82.43 | 2022-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Alnylam Pharmaceuticals INC. | $79.47 | 2021-2024 | Onpattro |
| Averitas Pharma INC. | $78.87 | 2023-2024 | Qutenza |
| Merz Pharmaceuticals, LLC | $78.10 | 2022-2025 | Xeomin |
| Axsome Therapeutics, INC. | $72.93 | 2025 | Sunosi, Symbravo |
| Catalyst Pharmaceuticals, INC. | $69.97 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $66.33 | 2022-2025 | Keveyis |
| Avanir Pharmaceuticals, INC. | $66.32 | 2021 | |
| Ge Healthcare | $65.80 | 2024-2025 | |
| Acorda Therapeutics, INC | $57.35 | 2023 | Ampyra, Inbrija |
| Janssen Biotech, INC. | $57.18 | 2025 | |
| Sunovion Pharmaceuticals INC. | $55.27 | 2021 | |
| Genentech, INC. | $55.21 | 2023 | Enspryng |
| Arbor Pharmaceuticals, INC. | $50.81 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $45.53 | 2023 | Nuplazid |
| Vanda Pharmaceuticals INC. | $45.22 | 2024 | Ponvory |
| Kyowa Kirin, INC. | $42.70 | 2023-2024 | Nourianz |
| Sandoz INC. | $31.03 | 2023 | |
| Cala Health, INC. | $20.91 | 2022 | |
| Avion Pharmaceuticals | $20.17 | 2022 | |
| Inogen, INC. | $19.89 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mylan Specialty L.P. | $19.56 | 2022 | |
| Merck Sharp & Dohme LLC | $19.49 | 2022 | |
| Corium, LLC | $17.10 | 2022 | |
| Impel Pharmaceuticals LLC | $15.31 | 2025 | Trudhesa |
| Inspire Medical Systems, INC. | $15.20 | 2025 | Inspire |
| Aucta Pharmaceuticals, INC. | $10.22 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Duffy-Henriques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.